Steeve Néron
Corporate Officer/Principal bei TETRA BIO-PHARMA INC.
Profil
Steeve Néron is currently the Director at TALLC Corp., Inc. and the Chief Commercial Officer at Tetra Bio-Pharma, Inc. He previously worked as the Senior Portfolio Manager at Valeant Canada Ltd.
from 2013 to 2018.
Mr. Néron completed his undergraduate degree from Université du Québec à Chicoutimi in 1986.
Aktive Positionen von Steeve Néron
Unternehmen | Position | Beginn |
---|---|---|
TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 17.09.2020 |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Steeve Néron
Unternehmen | Position | Ende |
---|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01.02.2018 |
Ausbildung von Steeve Néron
Université du Québec à Chicoutimi | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TETRA BIO-PHARMA INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |